Drug-eluting versus nondrug peripheral vascular interventions

  • Enezate T, Bath A, Chinta V, Omran J
  • Arch Med Sci Atheroscler Dis.
  • 2022 Jul 7
  • 7:e24-e28. doi: 10.5114/amsad.2022.116658.eCollection 2022 PMID: 35846409

AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: A Systematic Review

  • Enezate T, Alkhatib D, Raja J, Chinta V, Patel M, Omran J
  • ACurr Cardiol Reppr
  • 2022
  • 24(4):377-382. doi: 10.1007/s11886-022-01658-9. Epub 2022 Feb7. PMID: 35129741

Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement

  • Ghrair F, Omran J, Thomas J, Gifft K, Allaham H, Eniezat M, Kumar A, Enezate T
  • Atheroscler Dis
  • 2020 Dec 27
  • 5:e284-e289. doi: 10.5114/amsad.2020.103092.eCollection 2020. PMID: 33644487

Percutaneous versus surgical revascularization for acute myocardial infarction

  • Enezate T, Grifft K, Chen C, Omran J, Eniezat M, Reardon M
  • Cardiovasc Revasc Med
  • 2020 Dec 11
  • S1553-8389(20)30798-3. doi: 10.1016/j.carrev.2020.12.012. PMID: 33339773

Percutaneous Mitral Valve Therapies: The Old, Current, and Future

  • Fadi Ghrair MD, Jad Omran MD
  • American Collage of Cardiology
  • April 2020
  • https://www.acc.org/latest-in-cardiology/articles/2020/07/31/08/28/percutaneous-mitral-valve-therapies

Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip)

  • Gifft K, Omran J, Ghrair F, Allaham H, Eniezate M, Abdullah O, Enezate T
  • Catheter Cardiovasc Interventions
  • 2020 Nov 28
  • doi: 10.1002/ccd.29404. Online ahead of print PMID: 33247885

Important Interventional Trials From EuroPCR 2020

  • George W. Vetrovec, MD, MACC ; Syed Tanveer Rab, MBBS, FACC; Rahman Shah, MBBS; David Alan Cox, MD, FACC; Jad Omran, MD; Alina M. Robert, MD, FACC
  • American Collage of Cardiology
  • August 2020
  • https://www.acc.org/latest-in-cardiology/articles/2020/07/31/08/28/percutaneous-mitral-valve-therapies

Outcomes of percutaneous mitral valve repair in systolic versus diastolic congestive heart failure

  • Allaham H, Omran J, Burstein S, Ghrair F, Davis I, Chahal D, Enezate T
  • Cardiovasc Revasc Med
  • 2020 Jul 31
  • S1553-8389(20)30462-0. doi: 10.1016/j.carrev.2020.07.035. PMID: 32888837

Outcomes of Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure.

  • Enezate T, Omran J, Abdullah O, Mahmud E
  • The British Journal of Cardiology
  • Cardiol 2019
  • 26:149–52doi:10.5837/bjc.2019.033

Atherectomy-assisted versus percutaneous angioplasty interventions for treatment of symptomatic infra-inguinal peripheral arterial disease.

  • Abdullah O, Omran J, Al-Dadah AS, Aggarwal K, Enezate T
  • Arch Med Sci Atheroscler Dis.
  • 2019 Nov 21
  • 4:e231-e242. doi: 10.5114/amsad.2019.89900. eCollection 2019. PMID: 31824991
Load More

Echocardiography

Stress Testing

Non-Invasive Vascular Testing

Remote Heart Monitoring

{"cpt":"testimonial","style":"2","columns":"1","show":"6","order":"DESC","orderby":"none"}

*Dr. Omran spoke to *Dr. Mat Pugh & *Dr. Kaveh Bagheri to provide me with the proper care I needed. He always ask if I have questions. There is NO ONE I trust more.

Carol J.

Dr. Omran always listens to my concerns and gives me the best advice. I feel really well after the visit.

Michael T.

Dr. Omran is very thorough and caring. I trust him explicitly.

Stephanie R.

Dr. Omran and his staff have always been very professional when dealing with me.

Fred K.

Dr. Omran & his staff make you feel very cared for. They all listen & give you all the time you need – never rushed.

William M.

Dr.Omran took time to talk to my wife & I. He clearly described what the plan of care is.

Efren C.

Phone: 619-434-4288
Fax: 619-434-4315

info@omrancardiology.com

220 West Main Street Unit 103, El Cajon, CA 29020

PUBLICATIONS

Copyright © 2025 Jad Omran MD

Percutaneous Mitral and Tricuspid Valve Repair/Replacement

This is a minimally invasive heart procedure aimed at treating the mitral or tricuspid valves, which control blood flow between the heart chambers. Problems like valve leakage (regurgitation) or narrowing (stenosis) can disrupt blood flow and strain the heart.

How it works:
  • A catheter (thin tube) is inserted through a vein in the leg and guided to the heart.
  • For mitral and tricuspid valves, different devices can either repair the valve or replace it entirely.
  • This avoids the need for open-heart surgery, reducing recovery time and risks.
When it’s needed:
  • In patients with severe valve regurgitation (backflow of blood) or stenosis (narrowing).
  • For those who are not candidates for traditional open-heart surgery.
Benefits:
  • Restores proper blood flow.
  • Reduces symptoms like shortness of breath and fatigue.
  • Minimizes complications compared to traditional surgery.